COVID-19 therapy, from lung disease to systemic disorder
Saved in:
Main Authors: | Simon Pitchford (Author), Isabella Zanella (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
by: Jinxiang Xi, et al.
Published: (2021) -
Therapeutic Strategies for COVID-19 Lung Disease in Children
by: Elisabetta Gatti, et al.
Published: (2022) -
Arginine Therapy for Lung Diseases
by: Jeremy A. Scott, et al.
Published: (2021) -
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19
by: B. Solun, MD, et al.
Published: (2020) -
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study
by: Daniela Oatis, et al.
Published: (2024)